肝细胞癌分子影像诊断进展

刘钊; 马文婷; 张鹏飞; 黎金葵; 肖建喜; 雷军强

doi:10.3969/j.issn.1001-5256.2018.04.038

肝细胞癌分子影像诊断进展

DOI: 10.3969/j.issn.1001-5256.2018.04.038

1. 兰州大学第一临床医学院
2. 兰州大学第一医院
3. 兰州大学第二临床医学院
4. 兰州大学化学化工学院有机与功能国家重点实验室

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1867
- HTML全文浏览量: 12
- PDF下载量: 406
- 被引次数: 0
出版历程
- 出版日期: 2018-04-20

Research advances in molecular imaging of hepatocellular carcinoma

The First Clinical Medical College, Lanzhou University

摘要

摘要: 肝细胞癌是高死亡率的恶性肿瘤之一,其早期诊断将直接影响治疗方案及预后。分子影像是目前最先进的诊断与评估手段,同时是肝细胞癌早期诊断研究的重要方向。介绍了分子影像的定义和意义、分子影像成像基本步骤,并论述了肝细胞癌成像的有关靶点及肝细胞癌分子影像未来的研究方向。
- 癌,肝细胞 /
- 诊断显像 /
- 综述
Abstract: Hepatocellular carcinoma (HCC) is one of the malignancies with high mortality, and early diagnosis of this disease will directly affect its treatment regimens and prognosis.At present, molecular imaging is not only the most advanced diagnostic and evaluation method, but also an important research direction for the early diagnosis of HCC.This article introduces the definition and significance, as well as basic steps, of molecular imaging and discusses related targets in HCC imaging and the future direction of research on the molecular imaging of HCC.
- carcinoma, hepatocellular /
- diagnostic imaging /
- review

HTML全文

参考文献(50)

[1]LU LG.Advances in early screening and diagnosis of hepatocellular carcinoma[J].J Clin Hepatol, 2017, 33 (7) :1257-1261. (in Chinese) .陆伦根.原发性肝癌的早期筛查及诊断[J].临床肝胆病杂志, 2017, 33 (7) :1257-1261.

[2]KRISHNAN S, MADSEN E, PORTERFILEL D, et al.Advancing cervical cancer prevention in India:implementation science priorities[J].Oncologist, 2013, 18 (Suppl) :13-25.

[3]ZHANG CY, FU Y, LI XD, et al.Advances in imaging diagnosis of liver cancer[J].J Clin Hepatol, 2017, 33 (7) :1266-1269. (in Chinese) .张春雨, 付宇, 李晓东, 等.肝癌的影像学诊断进展[J].临床肝胆病杂志, 2017, 33 (7) :1266-1269.

[4]KIERANS AS, KANG SK, ROSENKRANTZ AB, et al.The diagnostic performance of dynamic contrast enhanced mr imaging for detection of small hepatocellular carcinoma measuring up to 2 cm:a meta-analysis[J].Radiology, 2016, 278 (1) :82-94.

[5]BLONDIN D, ERHARDT A, CRYNEN K, et al.Diagnosis of focal liver lesions in cirrhotic patients:comparison of contrast-enhanced ultrasound using sulphur hexafluoride (SF6) microbubbles and MRI using Gd-EOB-DTPA[J].Z Gastroenterol, 2011, 49 (1) :23-29.

[6]SAADATPOUR Z, REZAEI A, EBRAHIMNEJAD H, et al.Imaging techniques:new avenues in cancer gene and cell therapy[J].Cancer Gene Ther, 2017, 24 (1) :1-5.

[7]OKAMURA S, SUMIE S, TONAN T, et al.Diffusion-weighted magnetic resonance imaging predicts malignant potential in small hepatocellular carcinoma[J].Dig Liver Dis, 2016, 48 (8) :945-952.

[8]HERNANDEZ R, SUN H, ENGLAND CG, et al.CD146-targeted immuno PET and NIRF imaging of hepatocellular carcinoma with a dual-labeled monoclonal antibody[J].Theranostics, 2016, 6 (11) :1918-1933.

[9]WACHSMANN J, PENG F.Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma[J].World J Gastroenterol, 2016, 22 (1) :221-231.

[10]CARAVAN P, DAS B, DUMAS S, et al.Collagen-targeted MRI contrast agent for molecular imaging of fibrosis[J].Angew Chem Int Ed Engl, 2007, 46 (43) :8171-8173.

[11]LI YW, CHEN ZG, ZHAO ZS, et al.Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma[J].World J Gastroenterol, 2015, 21 (14) :4275-4283.

[12]LIU J, ZHOU S, REN J, et al.A lysosome-locating and acidic p H-activatable fluorescent probe for visualizing endogenous H2O2in lysosomes[J].Analyst, 2017, 142 (23) :4522-4528.

[13]LIU C, GAO Z, ZENG J, et al.Magnetic/upconversion fluorescent Na Gd F4:Yb, Er nanoparticle-based dual-modal molecular probes for imaging tiny tumors in vivo[J].ACS Nano, 2013, 7 (8) :7227-7240.

[14]WANG LW, LIU YY, BAI Y, et al.Study of early warning of liver cancer by AFP-L3 determined in AFP low concentrations[J].J Binzhou Med Univ, 2012, 35 (5) :362-364. (in Chinese) 王连文, 刘永云, 白玉, 等.甲胎蛋白异质体L3在甲胎蛋白低浓度时预警肝癌的研究[J].滨州医学院学报, 2012, 35 (5) :362-364.

[15]SONG JH.Specific MR imaging of hepatocellular carcinoma using AFP-targeted USPIO molecular probe[D].Jinan:Shandong Univ, 2012. (in Chinese) 宋吉慧.AFP靶向USPIO分子探针在肝癌特异性MR成像中的价值[D].济南:山东大学, 2012.

[16]LI Y, CHEN Z, LI F, et al.Preparation and in vitro studies of MRI-specific superparamagnetic iron oxide anti GPC3 probe for hepatocellular carcinoma[J].Int J Nanomedicine, 2012, 7:4593-4611.

[17]KIM KI, CHUNG HK, PARK JH, et al.Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma[J].World J Gastroenterol, 2016, 22 (27) :6127-6134.

[18]KIM S, YOUN H, SONG MG, et al.Complementary treatment of si TERT for improving the antitumor effect of TERT-specific I-131therapy[J].Cancer Gene Ther, 2012, 19 (4) :263-270.

[19]BHANG HE, GABEIELSON KL, LATERRA J, et al.Tumorspecific imaging through progression elevated gene-3 promoterdriven gene expression[J].Nat Med, 2011, 17 (1) :123-129.

[20]PARK JH, KIM KI, LEE KC, et al.Assessment ofα-fetoprotein targeted HSV1-tk expression in hepatocellular carcinoma with in vivo imaging[J].Cancer Biother Radiopharm, 2015, 30 (1) :8-15.

[21]KASEB AO, HASSAN M, LACIN S, et al.Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma[J].Oncotarget, 2016, 7 (43) :69916-69926.

[22]JEON Y, JANG ES, CHIO YS, et al.Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alphafetoprotein level for hepatocellular carcinoma diagnosis[J].Clin Mol Hepatol, 2016, 22 (3) :359-365.

[23]LIU X, WANG SK, ZHANG K, et al.Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers[J].Carcinogenesis, 2015, 36 (2) :232-242.

[24]SHAM JG, KIEVIT FM, GRIERSON JR, et al.Glypican-3-targeting F (ab') 2 for 89Zr PET of hepatocellular carcinoma[J].J Nucl Med, 2014, 55 (12) :2032-2037.

[25]LEE YL, AHN BC, LEE Y, et al.Targeting of hepatocellular carcinoma with glypican-3-targeting peptide ligand[J].J Pept Sci, 2011, 17 (11) :763-769.

[26]LI WY.MR Molecular Imaging Shidies of Glypican-3-targeting pretargeting technology for hepatocellular carcinoma[D].Guangzhou:Southern Med Univ, 2015. (in Chinese) 李维粤.靶向磷脂酰肌醇蛋白聚糖-3-预定位法检测肝细胞癌的MRI研究[D].广州:南方医科大学, 2015.

[27]ZHU D, QIN Y, WANG J, et al.Novel glypican-3-binding peptide for in vivo hepatocellular carcinoma fluorescent imaging[J].Bioconjug Chem, 2016, 27 (3) :831-839.

[28]QU Z, JIANG C, WU J, et al.Lenalidomide induces apoptosis and inhibits angiogenesis via caspase 3 and VEGF in hepatocellular carcinoma cells[J].Mol Med Rep, 2016, 14 (5) :4781-4786.

[29]LIU Y, CHEN Z, LIU C, et al.Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer[J].Biomaterials, 2011, 32 (22) :5167-5176.

[30]PANVICHIAN R, TANTIWETRUEANGDET A, SORNMAYURA P, et al.Missense mutations in exons 18-24 of EGFR in hepatocellular carcinoma tissues[J].Biomed Res Int, 2015, 2015:171845.

[31]SOGAWA C, TSUJI AB, YOSHIDA C, et al.Novel human monoclonal antibody against epidermal growth factor receptor as an imaging probe for hepatocellular carcinoma[J].Nucl Med Commun, 2012, 33 (7) :719-725.

[32]ZHAO P, YANG X, QI S, et al.Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes[J].Biomed Res Int, 2013, 2013:759057.

[33]YUAN S, FANG X, XU Y, et al.An oncolytic adenovirus that expresses the HAb18 and interleukin 24 genes exhibits enhanced antitumor activity in hepatocellular carcinoma cells[J].Oncotarget, 2016, 7 (37) :60491-60502.

[34]QIU K, WANG BC, CHEN ZN, et al.99m Tc-labeled HAb18Mc Ab Fab fragment for radioimmunoimaging in nude mice bearing human hepatocellular carcinoma[J].World J Gastroenterol, 1998, 4 (2) :117-120.

[35]LIU YL.The targeted-direeted probe (Hab18-SPIO) and its experimental study in the nude mice model gratfed with human HCC[D].Xi'an:The Fourth Military Med Univ, 2004. (in Chinese) 刘燕丽.Hab18-SPIO磁共振造影剂的制备及其在荷人肝癌裸鼠模型中的实验研究[D].西安:第四军医大学, 2004.

[36]ZHANG SW.An experimental study of MRI targeted diagnosis of hepatocellular carcinoma by Habl8 coupled SPIO[D].Changsha:Central South Univ, 2013. (in Chinese) 张声旺.Hab18偶联SPIO靶向肝癌MR诊断的实验研究[D].长沙:中南大学, 2013.

[37]WU SP, LU WS, XU DW, et al.Hepatic intraarterial 131Ⅰ-HAb18F (ab') 2 radioimmunotherapy on PLC with different types of blood supply through DSA[J].J Intervent Radiol, 2007, 16 (4) :243-245. (in Chinese) 吴少平, 卢武胜, 徐大伟, 等.肝癌DSA血供类型与经肝动脉灌注~ (131) Ⅰ-HAb18F (ab') _2治疗后瘤体大小变化的关系探讨[J].介入放射学杂志, 2007, 16 (4) :243-245.

[38]YANG R, AN LY, MIAO QF, et al.Effective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes[J].Oncotarget, 2016, 7 (24) :35894-35916.

[39]ZHAO RC, ZHOU J, CHEN KF, et al.The prognostic value of combination of CD90 and OCT4 for hepatocellular carcinoma after curative resection[J].Neoplasma, 2016, 63 (2) :288-298.

[40]LIU MC, LIU L, WANG XR, et al.Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo[J].Int J Nanomedicine, 2016, 11:1395-1412.

[41]WANG ZL, GUO L, LI YG, et al.Preparation of folate-mediated superparamagnetic iron oxide-dopamine-folate and its in vitro MR imaging[J].Chin J Med Imaging Technol, 2011, 27 (2) :251-255. (in Chinese) 王中领, 郭亮, 李勇刚, 等.叶酸靶向超顺磁性氧化铁-多巴胺-叶酸纳米复合物的制备及体外MR成像[J].中国医学影像技术, 2011, 27 (2) :251-255.

[42]HUO T, DU X, ZHANG S, et al.Gd-EDDA/HYNIC-RGD as an MR molecular probe imaging integrin alphanubeta 3 receptorexpressed tumor-MR molecular imaging of angiogenesis[J].Eur J Radiol, 2010, 73 (2) :420-427.

[43]GUO Z, GAO M, ZHANG D, et al.Simultaneous SPECT imaging of multi-targets to assist in identifying hepatic lesions[J].Sci Rep, 2016, 6:28812.

[44]HE H, TU X, ZHANG J, et al.A novel antibody targeting CD24 and hepatocellular carcinoma in vivo by near-infrared fluorescence imaging[J].Immunobiology, 2015, 220 (12) :1328-1336.

[45]WANG L, SU W, LIU Z, et al.CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma[J].Biomaterials, 2012, 33 (20) :5107-5114.

[46]MA X, CHENG Z, JIN Y, et al.SM5-1-conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy[J].Biomaterials, 2014, 35 (9) :2878-2889.

[47]CAI B, HUANG Z, WU Z, et al.Fabrication of RGD-conjugated Gd (OH) (3) :Eu nanorods with enhancement of magnetic resonance, luminescence imaging and in vivo tumor targeting[J].Dalton Trans, 2016, 45 (36) :14063-14070.

[48]LIU J, ZHOU S, REN J, et al.A lysosome-locating and acidic p H-activatable fluorescent probe for visualizing endogenous H2O2in lysosomes[J].Analyst, 2017, 142 (23) :4522-4528.

[49]van der VORST JR, SCHAAFSMA BE, HUTTEMAN M, et al.Near-infrared fluorescence-guided resection of colorectal liver metastases[J].Cancer, 2013, 119 (18) :3411-3418.

[50]LIU Y, ZHAO YM, AKERS W, et al.First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent:a pilot study[J].Transl Res, 2013, 162 (5) :324-331.

施引文献

资源附件(0)

访问统计